Myeloproliferative Neoplasm Clinical Trials

151 clinical trials for Myeloproliferative Neoplasm across international registries, including 40 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Functional and Phenotypic Characterization of Monocytes in Myeloproliferative Syndromes — RECRUITING · NA
• Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant — RECRUITING · PHASE2
• A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant — RECRUITING · PHASE1
• Improving Cognitive Function in Older Adults Undergoing Stem Cell Transplant — RECRUITING · NA
• Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Diseases — RECRUITING · PHASE2
• Evaluation of the Pathobiology of CALR-mutated MPN Cells — RECRUITING
• Study of Venetoclax and Azacitidine in Advanced BCR-ABL Negative Myeloproliferative Neoplasms — RECRUITING · PHASE2
• Allo HSCT Using RIC and PTCy for Hematological Diseases — RECRUITING · PHASE2
• Caris Chromoseq Data Collection — RECRUITING
• Thiotepa-based Conditioning Regimen With De-escalated Post-graft Cyclophosphamide for Allogeneic Stem Cell Transplantation in Hematologic Malignancies — RECRUITING · PHASE1
• Vedolizumab Plus Post-transplant Cyclophosphamide and Short Course Tacrolimus for the Prevention of Graft Versus Host Disease in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation After Reduced Intensity Conditioning — RECRUITING · PHASE2
• Preemptive CIML NK Cell Therapy After Hematopoietic Stem Cell Transplantation — RECRUITING · PHASE1
• A Phase 1 Trial of CIML NK Cell Infusion for Myeloid Disease Relapse After Hematopoietic Cell Transplantation — RECRUITING · PHASE1
• CPX-351 and Ivosidenib for the Treatment of IDH1 Mutated Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome — RECRUITING · PHASE2
• Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution — RECRUITING
• Evaluation of Optical Genome Mapping in Phi Negative Myeloproliferative Neoplasia in the Detection of Acquired Cytogenetic Abnormalities — RECRUITING · NA
• Dexrazoxane Hydrochloride in Preventing Heart-Related Side Effects of Chemotherapy in Participants With Blood Cancers — RECRUITING · PHASE2
• Identification of MPN-specific Antigens and Anti-MPN TCRs in Myeloproliferative Neoplasm — RECRUITING
• Project: Every Child for Younger Patients With Cancer — RECRUITING
• Mechanism of Action of Interferon in the Treatment of Myeloproliferative Neoplasms — RECRUITING
• A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation — RECRUITING · PHASE2
• Decitabine With Ruxolitinib, Fedratinib or Pacritinib for the Treatment of Accelerated/Blast Phase Myeloproliferative Neoplasms — RECRUITING · PHASE2
• Graft Versus Host Disease-Reduction Strategies for Donor Blood Stem Cell Transplant Patients With Acute Leukemia or Myelodysplastic Syndrome (MDS) — RECRUITING · PHASE2
• Ivosidenib and Venetoclax With or Without Azacitidine in Treating Patients With IDH1 Mutated Hematologic Malignancies — RECRUITING · PHASE1
• An Optimal Dose Finding Study of N-Acetylcysteine in Patients With Myeloproliferative Neoplasms — RECRUITING · PHASE1
• CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant — RECRUITING · PHASE2
• Interest of CALR Allele Burden in Diagnosis and Follow-up of Patients With CALR Mutated Myeloproliferative Syndromes (CALRSUIVI) — RECRUITING · NA
• Identification of Factors Associated With Treatment Response in Patients With Polycythemia Vera, Essential Thrombocythemia, and Pre-myelofibrosis. — RECRUITING
• Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy — RECRUITING · PHASE1
• Leukemia and Lymphoma Society (LLS) Services Impact on Outcomes and Care — RECRUITING · NA
• Prognostic Value of NETosis Markers for Thrombosis During Myeloproliferative Neoplasms (AVATARE) — RECRUITING · NA
• SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry — RECRUITING
• Impact of Epigenetic Age on Clinic-biological Presentation and Prognosis in Myeloproliferative Neoplasms Epigenetic Age in Myeloproliferative Neoplasms (EpiC) — RECRUITING
• Determination of the Clonality Profile in Myeloproliferative Neoplasms and Association With the Thrombotic Complications (CLOJAK) — RECRUITING
• Children, Adolescents and Young Adults with Myeloproliferative Neoplasia: Study of Clinico-biological Characteristics and Complications (VYP) — RECRUITING
• Sorafenib Relapase Prophylaxis After HCT With PTBCy Regimen — RECRUITING · PHASE2
• BeFluBu vs FluBuRux Conditioning in Haploidentical HCT — RECRUITING · PHASE2
• Exploring the Impact of Monocytes in Myeloproliferative Neoplasia (EMYNEM) — RECRUITING
• Asian Myeloproliferative Neoplasm (MPN) Registry — RECRUITING
• Olverembatinib for FGFR1-rearranged Neoplasms — RECRUITING · PHASE2
• P1101 in Treating Patients With Early PMF or Overt PMF at Low or Intermediate-1 Risk — ACTIVE_NOT_RECRUITING · PHASE3
• Study of Flonoltinib Maleate Tablets in the Treatment of Proliferative Bone Marrow Tumors — WITHDRAWN · PHASE1
• Brain MRF in Children, Adolescents and Young Adults With Acute Leukemia — SUSPENDED · NA
• Phase I Trial of Pacritinib in Combination With Venetoclax and Azacitidine for the Treatment of Accelerated and Blast Phase Myeloproliferative Neoplasms — NOT_YET_RECRUITING · PHASE1
• Venetoclax in Combination With ASTX727 for the Treatment of Chronic Myelomonocytic Leukemia and Other Myelodysplastic Syndrome/Myeloproliferative Neoplasm — ACTIVE_NOT_RECRUITING · PHASE2
• Efficacy and Safety of Ropeginterferon Alfa 2b (P1101) for Patients With Polycythemia Vera — WITHDRAWN · PHASE4
• Combination Chemotherapy (FLAG-Ida) With Pivekimab Sunirine (PVEK) for the Treatment of Newly Diagnosed Adverse Risk Acute Myeloid Leukemia and Other High-Grade Myeloid Neoplasms — ACTIVE_NOT_RECRUITING · PHASE1
• Multi-antigen CMV-MVA Triplex Vaccine in Reducing CMV Complications in Patients Previously Infected With CMV and Undergoing Donor Hematopoietic Cell Transplant — ACTIVE_NOT_RECRUITING · PHASE2
• Azacitidine, Venetoclax, and Pevonedistat in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia — ACTIVE_NOT_RECRUITING · PHASE1
• Comparing the Addition of an Anti-Cancer Drug, Pomalidomide, to the Usual Chemotherapy Treatment (Daunorubicin and Cytarabine Liposome) in Newly Diagnosed Acute Myeloid Leukemia With Myelodysplastic Syndrome-Related Changes — ACTIVE_NOT_RECRUITING · PHASE2

Refine this search